Direkt zum Inhalt
Merck
  • Identification of the full-length huntingtin- interacting protein p231HBP/HYPB as a DNA-binding factor.

Identification of the full-length huntingtin- interacting protein p231HBP/HYPB as a DNA-binding factor.

Molecular and cellular neurosciences (2001-07-20)
S Rega, T Stiewe, D I Chang, B Pollmeier, H Esche, W Bardenheuer, G Marquitan, B M Pützer
ZUSAMMENFASSUNG

Neurodegeneration in Huntington's disease (HD) is associated with an elongated glutamine tract in the widely expressed huntingtin protein. Although the pathogenic mechanisms are still unknown, the distinct physical properties of mutant huntingtin in the brain suggest that other factors including huntingtin-interacting proteins might play a specific role. We have previously identified a DNA-binding motif in the proximal E1A promoter of adenovirus serotype 12 as responsible for E1A autoregulation. Here, we identified the p231HBP protein as a DNA-binding factor, the C-terminal portion of which has recently been characterized as the huntingtin-interacting protein HYPB of unknown function. We have determined the full-length cDNA sequence, identified several domains supporting its gene regulatory functions, and mapped the HBP231 gene to chromosome 3p21.2-p21.3. Our results provide an interesting molecular link between huntingtin and a DNA-binding factor, implicating that this interaction might result in the alteration of cellular gene expression involved in HD pathogenesis.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
SETD2 active human, recombinant, expressed in E. coli, ≥70% (SDS-PAGE)